| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |